TUZIL, Jan, Barbora FILKOVA PILNACKOVA, Torquil WATT, Jan JISKRA, Marcela KOUDELKOVÁ, Eva NOVOTNA, Klara TUZILOVA, Tomáš DOLEŽAL and Jana BARTAKOVA. The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39. Value in health. NEW YORK: ELSEVIER SCIENCE INC, 2023, vol. 26, No 7, p. 1085-1097. ISSN 1098-3015. Available from: https://dx.doi.org/10.1016/j.jval.2023.02.015.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39
Authors TUZIL, Jan (203 Czech Republic, guarantor), Barbora FILKOVA PILNACKOVA (203 Czech Republic), Torquil WATT, Jan JISKRA (203 Czech Republic), Marcela KOUDELKOVÁ (203 Czech Republic, belonging to the institution), Eva NOVOTNA (203 Czech Republic), Klara TUZILOVA (203 Czech Republic), Tomáš DOLEŽAL (203 Czech Republic, belonging to the institution) and Jana BARTAKOVA (203 Czech Republic).
Edition Value in health, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1098-3015.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.500 in 2022
RIV identification code RIV/00216224:14110/23:00133293
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jval.2023.02.015
UT WoS 001029792800001
Keywords in English EQ-5D; hypothyroidism; pregnancy; quality of life; ThyPRO-39
Tags 14110516, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/1/2024 12:57.
Abstract
Objectives: To describe how subclinical hypothyroidism (SubHypo) influences the quality of life (QoL) during pregnancy. Methods: In primary data collection (NCT04167423), thyroid stimulating hormone (TSH), free thyroxine (FT4), thyroid peroxidase antibodies, generic quality of life (QoL; 5-level version of EQ-5D [EQ-5D-5L]), and disease-specific QoL (ThyPRO-39) were measured among pregnant women. SubHypo during each trimester was defined according to the 2014 European Thyroid Association guidelines (TSH . 2.5, 3.0, and 3.5 IU/L, respectively; with normal FT4). Path analysis described relationships and tested mediation. Linear ordinary least squares, beta, tobit, and two-part regressions were used to map ThyPRO-39 and EQ-5D-5L. Alternative SubHypo definition was tested in sensitivity analysis. Results: A total of 253 women at 14 sites (31 & PLUSMN; 5 years old, 15 & PLUSMN; 6 weeks pregnant) completed the questionnaires. Sixty-one (26%) had SubHypo and differed from 174 (74%) euthyroid women in smoking history (61% vs 41%), primiparity (62% vs 43%) and TSH level (4.1 & PLUSMN; 1.4 vs 1.5 & PLUSMN; 0.7 mIU/L, P < .001). EQ-5D-5L utility in SubHypo (0.89 & PLUSMN; 0.12) was lower than that in euthyroid (0.92 & PLUSMN; 0.11; P = .028) even after adjustment (difference 20.04, P = .033), whereas ocular (P = .001, ThyPRO-39), cognitive symptoms (P = .043), anxiety (P < .0001), and the composite score were higher. The impact of SubHypo on utility was mediated by anxiety. Results were confirmed by sensitivity analysis. Final mapping equation (ordinary least squares) includes goiter symptoms, anxiety, upset stomach, composite score (ThyPRO-39), FT4 levels, and week of pregnancy (determination coefficient 0.36). Conclusion: This is the first QoL mapping of SubHypo during pregnancy and the first evidence that SubHypo is associated with a negative impact on QoL. The effect is mediated by anxiety. EQ-5D-5L utilities can be generated based on ThyPRO-39 scores collected in pregnant euthyroid and patients with SubHypo.
PrintDisplayed: 21/7/2024 18:21